Literature DB >> 7580196

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment.

M A Weitzner1, C A Meyers, A D Valentine.   

Abstract

Psychostimulants used in the treatment of psychiatric conditions, including depression, alleviate some of the observed psychomotor retardation. We describe 3 patients with impairments of arousal and psychomotor speed secondary to tumor-related organic brain dysfunction who benefited from stimulant therapy.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7580196     DOI： 10.1176/jnp.7.3.347

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


  16 in total

1.  Phase II study of Ginkgo biloba in irradiated brain tumor patients: effect on cognitive function, quality of life, and mood.

Authors:  Albert Attia; Stephen R Rapp; L Doug Case; Ralph D'Agostino; Glenn Lesser; Michelle Naughton; Kevin McMullen; Robin Rosdhal; Edward G Shaw
Journal:  J Neurooncol       Date:  2012-06-15       Impact factor: 4.130

2.  Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue.

Authors:  Brandi R Page; Edward G Shaw; Lingyi Lu; David Bryant; David Grisell; Glenn J Lesser; Drew C Monitto; Michelle J Naughton; Stephen R Rapp; Steven R Savona; Sunjay Shah; Doug Case; Michael D Chan
Journal:  Neuro Oncol       Date:  2015-05-12       Impact factor: 12.300

Review 3.  Treatment of radiation-induced cognitive decline.

Authors:  Albert Attia; Brandi R Page; Glenn J Lesser; Michael Chan
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 4.  Depression and glioblastoma, complicated concomitant diseases: a systemic review of published literature.

Authors:  Luke Mugge; Tarek R Mansour; Megan Crippen; Yasaman Alam; Jason Schroeder
Journal:  Neurosurg Rev       Date:  2018-08-09       Impact factor: 3.042

5.  Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.

Authors:  Bruno Gagnon; Graeme Low; Gil Schreier
Journal:  J Psychiatry Neurosci       Date:  2005-03       Impact factor: 6.186

6.  A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor.

Authors:  K Gehring; S Y Patwardhan; R Collins; M D Groves; C J Etzel; C A Meyers; J S Wefel
Journal:  J Neurooncol       Date:  2011-10-02       Impact factor: 4.130

Review 7.  Managing the cognitive effects of brain tumor radiation therapy.

Authors:  Jerome M Butler; Stephen R Rapp; Edward G Shaw
Journal:  Curr Treat Options Oncol       Date:  2006-11

Review 8.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Authors:  Andrew H Miller; Sonia Ancoli-Israel; Julienne E Bower; Lucile Capuron; Michael R Irwin
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

9.  Decreased serum glucose levels after initiation of methylphenidate in a patient status post-cerebellar tumour resection: a potential interaction with glipizide.

Authors:  Samuel T Gontkovsky; Robert Nevels; Nicholas B McDonald; Michael H Winkelmann
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

Review 10.  Pharmacological interventions to treat or prevent neurocognitive decline after brain radiation.

Authors:  Jessica W Rooney; Nadia N Laack
Journal:  CNS Oncol       Date:  2013-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.